New pill aims to tame rare blood cancers in early trial
Disease control
Recruiting now
This study tests an experimental daily pill, JBI-802, in about 30 adults with certain blood cancers (MPN or MDS/MPN) that cause too many platelets. The goal is to check safety and see if the drug can lower platelet counts and shrink the cancer. Participants take the pill for up t…
Phase: PHASE1, PHASE2 • Sponsor: Jubilant Therapeutics Inc. • Aim: Disease control
Last updated Jun 17, 2026 05:28 UTC